JP2006089487A5 - - Google Patents

Download PDF

Info

Publication number
JP2006089487A5
JP2006089487A5 JP2005290190A JP2005290190A JP2006089487A5 JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5 JP 2005290190 A JP2005290190 A JP 2005290190A JP 2005290190 A JP2005290190 A JP 2005290190A JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5
Authority
JP
Japan
Prior art keywords
citrulline
active ingredient
antioxidant
active
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005290190A
Other languages
Japanese (ja)
Other versions
JP4691658B2 (en
JP2006089487A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005290190A priority Critical patent/JP4691658B2/en
Priority claimed from JP2005290190A external-priority patent/JP4691658B2/en
Publication of JP2006089487A publication Critical patent/JP2006089487A/en
Publication of JP2006089487A5 publication Critical patent/JP2006089487A5/ja
Application granted granted Critical
Publication of JP4691658B2 publication Critical patent/JP4691658B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (4)

シトルリンを有効成分として含有することを特徴とする、DNA切断防止剤。 A DNA cleavage inhibitor comprising citrulline as an active ingredient. シトルリンを有効成分として含有することを特徴とする、活性酸素に起因する疾患の治療薬または予防薬。 A therapeutic or prophylactic agent for diseases caused by active oxygen, comprising citrulline as an active ingredient. シトルリンを有効成分として含有することを特徴とする、抗酸化食品添加物。 An antioxidant food additive comprising citrulline as an active ingredient. シトルリンを有効成分として含有することを特徴とする、抗酸化用化粧品組成物。An antioxidant cosmetic composition comprising citrulline as an active ingredient.
JP2005290190A 2005-10-03 2005-10-03 Antioxidant food additive Expired - Fee Related JP4691658B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005290190A JP4691658B2 (en) 2005-10-03 2005-10-03 Antioxidant food additive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005290190A JP4691658B2 (en) 2005-10-03 2005-10-03 Antioxidant food additive

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001027772A Division JP3843298B2 (en) 2001-02-05 2001-02-05 Active oxygen scavenger containing citrulline

Publications (3)

Publication Number Publication Date
JP2006089487A JP2006089487A (en) 2006-04-06
JP2006089487A5 true JP2006089487A5 (en) 2006-07-20
JP4691658B2 JP4691658B2 (en) 2011-06-01

Family

ID=36230788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005290190A Expired - Fee Related JP4691658B2 (en) 2005-10-03 2005-10-03 Antioxidant food additive

Country Status (1)

Country Link
JP (1) JP4691658B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008105384A1 (en) * 2007-02-26 2010-06-03 協和発酵バイオ株式会社 Citrulline-containing tablets
JP5288788B2 (en) * 2007-12-28 2013-09-11 三菱鉛筆株式会社 Water-based ink composition
JP2014045683A (en) * 2012-08-30 2014-03-17 Fuji Oil Co Ltd Edible fat and oil, food product containing the same, and production method of the same
JP2014118405A (en) * 2012-12-19 2014-06-30 Kose Corp Dna damage inhibitor
JP2014129267A (en) * 2012-12-28 2014-07-10 Kose Corp DNA damage inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267319A (en) * 1984-09-12 1990-04-03 Godefridus Antonius Maria Van Den Ouweland Process for improving or modifying the taste and aroma of citrus fruit compositions
DE4341000A1 (en) * 1993-12-02 1995-06-08 Beiersdorf Ag Use of L-arginine, L-ornithine or L-citrulline and topical preparations with these substances
JPH09241637A (en) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd Composition for removing active oxygen free radical and removal thereof
US6028107A (en) * 1997-02-27 2000-02-22 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection

Similar Documents

Publication Publication Date Title
AU2007299727A8 (en) Self preserved aqueous pharmaceutical compositions
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2006091529A3 (en) A solid pharmaceutical dosage formulation
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2009137391A3 (en) Benzene sulfonamide thiazole and oxazole compounds
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2008006528A3 (en) Pharmaceutical compositions comprising levetiracetam
ZA200902632B (en) Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
EP2607348A3 (en) Plasminogen Activator Inhibitor-1 Inhibitor
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EP2045253A4 (en) alpha-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
CL2007003265A1 (en) COMPOUNDS DERIVED FROM 1H-PIRAN [2,3-D] PIRIMIDIN-2,4,7-TRIONA; AND PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF METABOLIC SYNDROME, DYSLIPIDEMIA AND CARDIOVASCULAR DISEASES BETWEEN OTHERS.
EP2078731A4 (en) Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
DK1932522T3 (en) Liver disease therapeutic agent containing 2-amino-1,3-propanediol derivative as active ingredient
NO20080220L (en) Formulations with high drug loading and dosage forms
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
WO2010021607A3 (en) Pharmaceutical formulation
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
IL185197A0 (en) Ophthalmological pharmaceutical compositions
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
JP2006089487A5 (en)
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments